Interní Med. 2015; 17(2): 74-78

Obesity and metabolic syndrome: do we know how much we do not know?

MUDr.Petr Sucharda, CSc.
III. interní klinika VFN a 1. LF UK, Praha a Český institut metabolického syndromu, o. p. s.

The quantitative definition of obesity (according to BMI) is no longer sufficient, because of reflecting neither the metabolic, nor the

functional burden for the patient. The concept of metabolic syndrome emphasizes the essential relevance of fat distribution, but does

not differentiate the risk of various combinations of the individual components of the syndrome. The Edmonton classification of obesity

reflects the fat distribution indirectly, by the presence of pathological conditions associated with visceral obesity.

Keywords: obesity, metabolic syndrome, Edmonton classification

Published: April 10, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sucharda P. Obesity and metabolic syndrome: do we know how much we do not know? Interní Med. 2015;17(2):74-78.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Reaven GM. Role of insulin resistance in human disease. Banting Lecture 1988. Diabetes 1988; 37: 1595-1607. Go to original source... Go to PubMed...
    2. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520. Go to original source... Go to PubMed...
    3. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34. Go to original source... Go to PubMed...
    4. Enzi G, Busetto L, Inelmen EM, Coin A, Sergi G. Historical perspective: visceral obesity and related comorbidity in Joannes Baptista Morgagni's 'De sedibus et causis morborum per anatomen indagata'. Int J Obes Relat Metab Disord 2003; 27: 534-535. Go to original source... Go to PubMed...
    5. Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 2012; 49: 89-95. Go to original source... Go to PubMed...
    6. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645. Go to original source... Go to PubMed...
    7. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247. Go to original source... Go to PubMed...
    8. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend R, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014; 32: 3-15. Go to original source... Go to PubMed...
    9. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480. Go to original source... Go to PubMed...
    10. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol 2007; 6: 13-19. Go to original source... Go to PubMed...
    11. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007; 30: 2381-2387. Go to original source... Go to PubMed...
    12. Rodriguez-Colon SM, Mo J, Duan Y, Liu J, Caulfield JE, Jin X, Liao D. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke 2009; 40: 200-205. Go to original source... Go to PubMed...
    13. Sucharda P. Metabolický syndrom - kliniku patofyziologií nenahradíš. Practicus 2014; 4: 14-16.
    14. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Bethesda (MD): National Heart, Lung, and Blood Institute; 1998 Sep. Report No.: 98-4083.
    15. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. JAMA 1987; 257: 353-358. Go to original source...
    16. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985; 103: 983-988.
    17. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999; 341: 1097-1105. Go to original source... Go to PubMed...
    18. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638. Go to original source... Go to PubMed...
    19. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371: 2237-2238. Go to original source... Go to PubMed...
    20. Samocha-Bonet D, Dixit VD, Kahn CR, Leibel RL, Lin X, Nieuwdorp M, Pietiläinen KH, Rabasa-Lhoret R, Roden M, Scherer PE, Klein S, Ravussin E. Metabolically healthy and unhealthy obese - the 2013 Stock Conference report. Obes Rev 2014; 15: 697-708. Go to original source... Go to PubMed...
    21. Dixon JB, Lambert GW. The obesity paradox - a reality that requires explanation and clinical interpretation. Atherosclerosis 2013; 226: 47-48. Go to original source...
    22. Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral JG, Imielinska C, Ross R, Heymsfield SB. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 2003; 11: 5-16. Go to original source... Go to PubMed...
    23. Kobayashi J, Tadokoro N, Watanabe M, Shinomiya M. A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int J Obes Relat Metab Disord 2002; 26: 398-402. Go to original source... Go to PubMed...
    24. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-161. Go to original source... Go to PubMed...
    25. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes 2009; 33: 289-295. Go to original source...
    26. Kushner RF. Clinical assessment and management of adult obesity. Circulation 2012; 126: 2870-2877. Go to original source...
    27. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 2011; 183: E1059-1066. Go to original source... Go to PubMed...
    28. Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, Blair SN. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011; 36: 570-576. Go to original source...
    29. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-1209. Go to original source...
    30. Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, D'Agostino RB Sr. Trajectories of entering the metabolic syndrome: the Framingham Heart Study. Circulation 2009; 120: 1943-1950. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.